REGN trade ideas
REGN Presents a good potential long opportunity. I am fairly new to analysis so take this with a grain of salt. But I believe REGN is in a downward channel and for the past two weeks or so has been hovering around two support levels. Due to the strong fundamentals of the company, and the fact that they beat earnings and have had only positive recent news. I believe that REGN is currently at a good buy point and will start climbing upward over the next few months(assuming no market correction/crash). Stoch indicates that REGN is oversold, and is trending upwards. The MACD just turned green, and there is bullish deviation between the RSI and the price (the right side of the most recent dip is higher up on the RSI than the price. Anyway, this is just my opinion not financial advice I would be interested in hearing others perspectives.
REGENERON strong fundamental at discounted price!Regeneron Pharmaceuticals (NASDAQ:REGN) has had a rough three months with its share price down 8.2%. But if you pay close attention, you might gather that its strong financials could mean that the stock could potentially see an increase in value in the long-term, given how markets usually reward companies with good financial health. Specifically, we decided to study Regeneron Pharmaceuticals' ROE in this article.
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. Put another way, it reveals the company's success at turning shareholder investments into profits.
$REGN - on the verge of break-outThe main thesis is that $REGN pattern is similar to $ABBV; though it needed a catalyst for reversal. Today's news is the one + earnings next week.
Target 1: $575 - short-term (earnings as catalyst)
Target 2: $615 - mid-term (post-earnings till next earnings)
Target 3: $650 - mid-year
REGN wedge bounceREGN has had its ups and downs, but since SEP 2019, a trendline was formed on the chart which we are now meeting again. Each time it met this trendline, the stock was met with a hard bounce. After running up to highs in July, the stock has been in a steady downtrend, which accelerated to the downside to meet the larger trendline. This is a great spot for a low risk, high reward long with the target at 505.55 to keep this play conservative. Because this play is contingent on a bounce almost immediately, the stop will be extremely tight and be placed at the break of the lower blue trendline , which will likely be about the 481-482 range, but price action can dictate otherwise. Due to the virus, this company can come out with random news extremely fast, so make sure to keep watch after entering, even if news is not likely.